Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/83104
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAng, Michelle Lay Tengen
dc.contributor.authorPethe, Kevinen
dc.date.accessioned2017-05-15T04:48:21Zen
dc.date.accessioned2019-12-06T15:11:57Z-
dc.date.available2017-05-15T04:48:21Zen
dc.date.available2019-12-06T15:11:57Z-
dc.date.issued2016en
dc.identifier.citationAng, M. L. T., & Pethe, K. (2016). Contribution of high-content imaging technologies to the development of anti-infective drugs. Cytometry Part A, 89(8), 755-760.en
dc.identifier.issn1552-4922en
dc.identifier.urihttps://hdl.handle.net/10356/83104-
dc.description.abstractOriginally developed to study fundamental aspects of cellular biology, high-content imaging (HCI) was rapidly adapted to study host–pathogen interactions at the cellular level and adopted as a technology of choice to unravel disease biology. HCI platforms allow for the visualization and quantification of discrete phenotypes that cannot be captured using classical screening approaches. A key advantage of high-content screening technologies lies in the possibility to develop and interrogate physiologically significant, predictive ex vivo disease models that reproduce complex conditions relevant for infection. Here we review and discuss recent advances in HCI technologies and chemical biology approaches that are contributing to an increased understanding of the intricate host–pathogen interrelationship on the cellular level, and which will foster the development of novel therapeutic approaches for the treatment of human bacterial and protozoan infections.en
dc.description.sponsorshipNMRC (Natl Medical Research Council, S’pore)en
dc.format.extent6 p.en
dc.language.isoenen
dc.relation.ispartofseriesCytometry Part Aen
dc.rights© 2016 The Authors. Cytometry Part A published by Wiley Periodicals, Inc. on behalf of ISAC. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.en
dc.subjectDrug discoveryen
dc.subjectAntimicrobialen
dc.titleContribution of high-content imaging technologies to the development of anti-infective drugsen
dc.typeJournal Articleen
dc.contributor.schoolLee Kong Chian School of Medicine (LKCMedicine)en
dc.identifier.doi10.1002/cyto.a.22885en
dc.description.versionPublished versionen
dc.identifier.pmid27272127-
item.grantfulltextopen-
item.fulltextWith Fulltext-
Appears in Collections:LKCMedicine Journal Articles
Files in This Item:
File Description SizeFormat 
Ang_et_al-2016-Cytometry_Part_A (1).pdf213.28 kBAdobe PDFThumbnail
View/Open

SCOPUSTM   
Citations 20

12
Updated on Jul 5, 2022

PublonsTM
Citations 20

11
Updated on Jul 10, 2022

Page view(s) 50

459
Updated on Aug 14, 2022

Download(s) 50

99
Updated on Aug 14, 2022

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.